Growing community of inventors

Lyons, France

Frederic Batt

Average Co-Inventor Count = 6.00

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 10

Frederic BattHamid R Hoveyda (4 patents)Frederic BattGraeme Lovat Fraser (4 patents)Frederic BattGuillaume Dutheuil (4 patents)Frederic BattMarie-Odile Roy (4 patents)Frederic BattMohamed El Bousmaqui (3 patents)Frederic BattMohamed E Bousmaqui (1 patent)Frederic BattFrederic Batt (4 patents)Hamid R HoveydaHamid R Hoveyda (51 patents)Graeme Lovat FraserGraeme Lovat Fraser (38 patents)Guillaume DutheuilGuillaume Dutheuil (20 patents)Marie-Odile RoyMarie-Odile Roy (10 patents)Mohamed El BousmaquiMohamed El Bousmaqui (3 patents)Mohamed E BousmaquiMohamed E Bousmaqui (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Ogeda Sa (3 from 23 patents)

2. Euroscreen S.a. (1 from 33 patents)


4 patents:

1. 10941151 - Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof

2. 10683295 - Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-A]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof

3. 10065961 - Chiral N-acyl-5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof

4. 9475814 - [object Object]

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/28/2025
Loading…